معرفی
David Byrd Singer is a Lecturer in Management at the Stanford Graduate School of Business, specializing in Accounting. He holds an MBA from Stanford (1988) and a BA in History from Yale University (1984). Currently, he leads private investments at Maverick and serves as Vice Chair of College Track. Singer has extensive experience as a founder and CEO of prominent biotech firms, including Affymetrix, Corcept Therapeutics, and Genesoft Pharmaceuticals. He has served on 28 private company boards, including seven that went public during his tenure.
- Educations:
- B.A. in History, Yale University, 1984
- M.B.A., Stanford Graduate School of Business, 1988
Research & Teaching: Focuses on managerial accounting perspectives in talent compensation, informed by his venture capital and corporate leadership experience. Teaches ACCT 220: Compensating Talent at Stanford.
Awards:
- Forbes’ Midas List (2023 and 2024) for top venture capital investors
Advising & Grants: No formal advisees listed; however, his board roles and entrepreneurial ventures suggest significant mentorship in biotech and venture capital sectors.
